share_log

Capricor Therapeutics Q1 EPS $(0.23) Up From $(0.30) YoY, Sales $40.82K Down From $185.69K YoY

Capricor Therapeutics Q1 EPS $(0.23) Up From $(0.30) YoY, Sales $40.82K Down From $185.69K YoY

Capricor Treeutics第一季度每股收益從0.30美元上升到0.23美元,銷售額從185.69K美元下降到40.82K美元
Benzinga Real-time News ·  2021/05/13 15:20

Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.23) per share. This is a 23.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported $40.82 thousand in sales this quarter. This is a 78.02 percent decrease over sales of $185.69 thousand the same period last year.

Capricor治療公司(納斯達克市場代碼:CAPR)公佈季度每股虧損0.23美元。這比去年同期每股虧損0.30美元增加了23.33%。該公司報告本季度銷售額為40.82萬美元。這比去年同期185.69萬美元的銷售額下降了78.02%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論